Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
84.00
+3.39 (4.21%)
At close: Sep 21, 2026, 4:00 PM EDT
84.00
0.00 (0.00%)
After-hours: Sep 21, 2026, 4:04 PM EDT
Celcuity Market Cap
Celcuity has a market cap or net worth of $4.11 billion as of September 21, 2026. Its market cap has increased by 86.74% in one year.
Market Cap
4.11B
Enterprise Value
4.11B
1-Year Change
86.74%
Ranking
Category
Stock Price
$84.00
ChartMarket Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $4.11B, an increase of 2,969.66%. That is a compound annual growth rate of 46.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 4.11B | -10.94% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veradermics | 4.46B |
| Telix Pharmaceuticals | 4.31B |
| Relay Therapeutics | 4.13B |
| AbCellera Biologics | 4.09B |
| Xenon Pharmaceuticals | 3.85B |
| IDEAYA Biosciences | 3.71B |
| Tango Therapeutics | 3.67B |
| Enliven Therapeutics | 3.62B |